|
Re: BTI:TSXV; BIOAF:OTCQB: "Announces Rare Diseases Strategic Alliance With Chiesi"
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2020 04:31PM
|
|
Re: BTI:TSXV; BIOAF:OTCQB: "Announces Rare Diseases Strategic Alliance With Chiesi"
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2020 04:16PM
|
|
Re: AACR 2020 Poster
|
4
|
Zenith Epigenetics
|
Jun 29, 2020 03:40PM
|
|
Re: Constellation Pharma
|
19
|
Resverlogix Corp.
|
Jun 29, 2020 12:23PM
|
|
Re: Constellation Pharma
|
13
|
Resverlogix Corp.
|
Jun 29, 2020 11:43AM
|
|
Re: Constellation Pharma
|
15
|
Resverlogix Corp.
|
Jun 29, 2020 10:46AM
|
|
Re: Constellation Pharma
|
14
|
Resverlogix Corp.
|
Jun 29, 2020 10:38AM
|
|
Re: Constellation Pharma
|
12
|
Resverlogix Corp.
|
Jun 29, 2020 10:17AM
|
|
Apabetalone and NAFLD
|
9
|
Resverlogix Corp.
|
Jun 29, 2020 10:00AM
|
|
AACR 2020 Poster
|
7
|
Zenith Epigenetics
|
Jun 29, 2020 07:21AM
|
|
Re: COVID 19 & BP
|
7
|
Resverlogix Corp.
|
Jun 27, 2020 10:48PM
|
|
Re: COVID 19 & BP
|
5
|
Resverlogix Corp.
|
Jun 27, 2020 10:25PM
|
|
Re: why I invested in Bioasis
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2020 12:26PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
8
|
Resverlogix Corp.
|
Jun 22, 2020 09:32AM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
4
|
Resverlogix Corp.
|
Jun 22, 2020 09:28AM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
4
|
Resverlogix Corp.
|
Jun 22, 2020 08:32AM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
8
|
Resverlogix Corp.
|
Jun 22, 2020 07:39AM
|
|
Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
7
|
Resverlogix Corp.
|
Jun 22, 2020 07:26AM
|
|
Re: Presentation slides are up
|
7
|
Zenith Epigenetics
|
Jun 18, 2020 11:33AM
|
|
Presentation slides are up
|
3
|
Zenith Epigenetics
|
Jun 18, 2020 10:59AM
|
